Lakshmi Bhargavi Paruchuru

Dr. Lakshmi Bhargavi Paruchuru

C / O Prof. Ehud Razin, Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah-Ein Kerem, POB 12272, Jerusalem- 9112001, Israel
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Maria ChelombitkoMaria Chelombitko
Maria Chelombitko
Boris V. ChernyakBoris V. Chernyak
Boris V. Chernyak
AFArtem V. Fedorov
Artem V. Fedorov
RZRoman A. Zinovkin
Roman A. Zinovkin
EREhud Razin
Ehud Razin
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
Mast cells play a key role in the regulation of innate and adaptive immunity and are involved in pathogenesis of many inflammatory and allergic diseases. The most studied mechanism of mast cell activation is mediated by the interaction of antigens with immunoglobulin E (IgE) and a subsequent binding with the high-affinity receptor Fc epsilon RI (FcεRI). Increasing evidences indicated that mitochondria are actively involved in the FcεRI-dependent activation of this type of cells. Here, we discuss changes in energy metabolism and mitochondrial dynamics during IgE-antigen stimulation of mast cells. We reviewed the recent data with regards to the role played by mitochondrial membrane potential, mitochondrial calcium ions (Ca2+) influx and reactive oxygen species (ROS) in mast cell FcεRI-dependent activation. Additionally, in the present review we have discussed the crucial role played by the pyruvate dehydrogenase (PDH) complex, transcription factors signal transducer and activator of transcription 3 (STAT3) and microphthalmia-associated transcription factor (MITF) in the development and function of mast cells. These two transcription factors besides their nuclear localization were also found to translocate in to the mitochondria and functions as direct modulators of mitochondrial activity. Studying the role played by mast cell mitochondria following their activation is essential for expanding our basic knowledge about mast cell physiological functions and would help to design mitochondria-targeted anti-allergic and anti-inflammatory drugs.

1 October 2013 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
RPR.S. Prakasham
R.S. Prakasham

Verified
Journal Article
Open access
PDF file
SBSabrina Bilotta
Sabrina Bilotta
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
KFKatharina Feilhauer
Katharina Feilhauer
JKJörg Köninger
Jörg Köninger
ALAxel Lorentz
Axel Lorentz
Mast cells play a critical role as main effector cells in allergic and other inflammatory diseases. Usage of anti-inflammatory nutraceuticals could be of interest for affected patients. Resveratrol, a natural polyphenol found in red grapes, is known for its positive properties. Here, we analyzed the effects of resveratrol on FcεRI-mediated activation of mature human mast cells isolated from intestinal tissue (hiMC). Resveratrol inhibited degranulation and expression of cytokines and chemokines such as CXCL8, CCL2, CCL3, CCL4, and TNF-α in a dose-dependent manner. Further, resveratrol inhibited the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and signal transducer and activator of transcription (STAT) 3. ERK1/2 is known to be involved in cytokine expression of hiMC and to directly interact with STAT3. Mitochondrial STAT3 is phosphorylated by ERK1/2 and contributes to mast cell degranulation. We were able to isolate mitochondrial fractions from small hiMC numbers and could show that activation of mitochondrial STAT3 and ERK1/2 in hiMC was also inhibited by resveratrol. Our results indicate that resveratrol inhibits hiMC activation by inhibiting the phosphorylation of mitochondrial and nuclear ERK1/2 and STAT3, and it could be considered as an anti-inflammatory nutraceutical in the treatment of mast cell-associated diseases.

8 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
SGSharmila Govindaraj
Sharmila Govindaraj
EREhud Razin
Ehud Razin
In recent years, growing evidence has indicated the pivotal role of mitochondria in mast cell immunological activation. We have previously reported a decrease in degranulation and cytokine secretion following the inhibition of pyruvate dehydrogenase (PDH) either by CPI-613 (PDH inhibitor/anti-cancer drug) or through its interaction with mitochondrial microphthalmia-associated transcription factor (MITF). In the present study, we further explored the role played by mitochondrial MITF in mast cell exocytosis using rat basophil leukemia cells [RBL], as well as mouse bone marrow-derived mast cells (BMMCs). Here, we report that mast cell degranulation, cytokine secretion and oxidative phosphorylation (OXPHOS) activities were associated with phosphorylation of Serine 73 of mitochondrial MITF, controlled by extracellular signals regulated by protein kinase (ERK1/2) activity. Also, we report here that decreased OXPHOS activity following ERK1/2 inhibition (U0126 treatment) during IgE-Ag activation was mediated by the dephosphorylation of Serine 73 mitochondrial MITF, which inhibited its association with PDH. This led to a reduction in mast cell reactivity. In addition, a phosphorylation-mimicking mitochondrial MITF-S73D positively regulated the mitochondrial activity, thereby supporting mast cell degranulation. Thus, the present research findings highlight the prominence of mitochondrial MITF Serine 73 phosphorylation in immunologically activated mast cells.

1 January 2017 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
RPReddy Shetty Prakasham
Reddy Shetty Prakasham

1 June 2019 in iScience
Verified
Journal Article
Open access
SSShin La Shu
Shin La Shu
Lakshmi Bhargavi ParuchuruLakshmi Bhargavi Paruchuru
Lakshmi Bhargavi Paruchuru
NTNeil Quanwei Tay
Neil Quanwei Tay
YCYen Leong Chua
Yen Leong Chua
AFAdeline Shen Yun Foo
Adeline Shen Yun Foo
DKDavid Michael Kemeny
David Michael Kemeny
The significance of intracellular Ap4A levels over immune activity of dendritic cells (DCs) has been studied in Nudt2fl/fl/CD11c-cre mice. The transgenic mice have been generated by crossing floxed NUDT2 gene mice with DC marker CD11c recombinase (cre) mice. The DCs derived from these mice have higher levels of Ap4A (≈30-fold) compared with those derived from Nudt2+/+ mice. Interestingly, the elevated Ap4A in DCs has led them to possess higher motility and lower directional variability. In addition, the DCs are able to enhance immune protection indicated by the higher cross-presentation of antigen and priming of CD8+ OT-I T cells. Overall, the study denotes prominent impact of Ap4A over the functionality of DCs. The Nudt2fl/fl/CD11c-cre mice could serve as a useful tool to study the influence of Ap4A in the critical immune mechanisms of DCs.